FDA recall D-0471-2026
PAYLESS COMPOUNDERS, LLC · Class II · drug
Product
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Reason for recall
Lack of Assurance of Sterility
Distribution
OR
Key facts
- Status
- Ongoing
- Initiation date
- 2026-03-06
- Report date
- 2026-04-22
- Voluntary/Mandated
- Voluntary: Firm initiated
- Location
- Beaverton, OR, United States
Primary source
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0471-2026